Michael H. Wilson

Array ( [id] => 6307804 [patent_doc_number] => 20020094952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Human therapeutic uses of BPI Protein products' [patent_app_type] => new [patent_app_number] => 09/733613 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12608 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094952.pdf [firstpage_image] =>[orig_patent_app_number] => 09733613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333121 [patent_doc_number] => 06596691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Therapeutic uses of BPI protein products for human meningococcemia' [patent_app_type] => B2 [patent_app_number] => 09/728938 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10253 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596691.pdf [firstpage_image] =>[orig_patent_app_number] => 09728938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327721 [patent_doc_number] => 06599878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => 'Superoxygenating blood substitutes based on hemoglobin and dihydropyidine compositions' [patent_app_type] => B2 [patent_app_number] => 09/727170 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10942 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599878.pdf [firstpage_image] =>[orig_patent_app_number] => 09727170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1167854 [patent_doc_number] => 06756482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Purified human activin and process for producing the same' [patent_app_type] => B1 [patent_app_number] => 09/721750 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6232 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756482.pdf [firstpage_image] =>[orig_patent_app_number] => 09721750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1598859 [patent_doc_number] => 06475507 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Sustained release compositions and the process for their preparation' [patent_app_type] => B1 [patent_app_number] => 09/707372 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7235 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475507.pdf [firstpage_image] =>[orig_patent_app_number] => 09707372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490589 [patent_doc_number] => 06417164 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Treatment of type II diabetes mellitus with amylin agonists' [patent_app_type] => B1 [patent_app_number] => 09/707370 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9005 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417164.pdf [firstpage_image] =>[orig_patent_app_number] => 09707370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1376048 [patent_doc_number] => 06562952 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Precipitation of proteins from organic solutions' [patent_app_type] => B1 [patent_app_number] => 09/703221 [patent_app_country] => US [patent_app_date] => 2000-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6589 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562952.pdf [firstpage_image] =>[orig_patent_app_number] => 09703221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347403 [patent_doc_number] => 06583116 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Anti-chlamydial methods and materials' [patent_app_type] => B1 [patent_app_number] => 09/699625 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10765 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583116.pdf [firstpage_image] =>[orig_patent_app_number] => 09699625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1239986 [patent_doc_number] => 06686332 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Method of treating depressed reticuloendothelial system function' [patent_app_type] => B1 [patent_app_number] => 09/689097 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 21531 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686332.pdf [firstpage_image] =>[orig_patent_app_number] => 09689097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1582237 [patent_doc_number] => 06423831 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Isolation of neurotrophins from a mixture containing other proteins and neurotrophin variants using hydrophobic interaction chromatography' [patent_app_type] => B1 [patent_app_number] => 09/675503 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 21269 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423831.pdf [firstpage_image] =>[orig_patent_app_number] => 09675503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068787 [patent_doc_number] => 06844313 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Composition containing a meiosis activating substance' [patent_app_type] => utility [patent_app_number] => 09/661696 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2301 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844313.pdf [firstpage_image] =>[orig_patent_app_number] => 09661696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270591 [patent_doc_number] => 06653279 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Treatment of inner ear hair cells' [patent_app_type] => B1 [patent_app_number] => 09/644368 [patent_app_country] => US [patent_app_date] => 2000-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 20 [patent_no_of_words] => 17441 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653279.pdf [firstpage_image] =>[orig_patent_app_number] => 09644368 [rel_patent_id] =>[rel_patent_doc_number] =>)